StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical cash

Cash and short-term investments held at the end of each period.

Acro Biomedical's cash was $3.65K at Jun 30, 2026. For fiscal 2025 it was $4.10K, up 760.9% from the year before. Over ten years it grew 0.4% a year on average. The highest annual figure on record is $95.25K in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$4.10K+760.9%
FY2024Dec 31, 2024$476+26.6%
FY2023Dec 31, 2023$376-93.6%
FY2022Dec 31, 2022$5.85K-93.9%
FY2021Dec 31, 2021$95.25K+6370.7%
FY2019Sep 30, 2019$1.47K+28.2%
FY2018Sep 30, 2018$1.15K-96.9%
FY2017Sep 30, 2017$36.81K+1353.2%
FY2016Sep 30, 2016$2.53K-90.7%
FY2015Sep 30, 2015$27.28K+594.9%
FY2014Sep 30, 2014$3.93K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$3.65K+13930.8%
Q1 FY2026CQ1 2026Mar 31, 2026$3.87K+1443.0%
Q4 FY2025CQ4 2025Dec 31, 2025$4.10K+760.9%
Q3 FY2025CQ3 2025Sep 30, 2025$4.32K+516.7%
Q2 FY2025CQ2 2025Jun 30, 2025$26-97.2%
Q1 FY2025CQ1 2025Mar 31, 2025$251+66.2%
Q4 FY2024CQ4 2024Dec 31, 2024$476+26.6%
Q3 FY2024CQ3 2024Sep 30, 2024$701-78.6%
Q2 FY2024CQ2 2024Jun 30, 2024$926-65.4%
Q1 FY2024CQ1 2024Mar 31, 2024$151-53.1%
Q4 FY2023CQ4 2023Dec 31, 2023$376-93.6%
Q3 FY2023CQ3 2023Sep 30, 2023$3.27K-79.8%
Q2 FY2023CQ2 2023Jun 30, 2023$2.68K-77.9%
Q1 FY2023CQ1 2023Mar 31, 2023$322-99.9%
Q4 FY2022CQ4 2022Dec 31, 2022$5.85K-93.9%
Q3 FY2022CQ3 2022Sep 30, 2022$16.19K-89.5%
Q2 FY2022CQ2 2022Jun 30, 2022$12.11K-94.4%
Q1 FY2022CQ1 2022Mar 31, 2022$357.67K+1368.3%
Q4 FY2021CQ4 2021Dec 31, 2021$95.25K+6370.7%
Q3 FY2021CQ3 2021Sep 30, 2021$154.66K+66853.7%
Q2 FY2021CQ2 2021Jun 30, 2021$215.49K+52204.4%
Q1 FY2021CQ1 2021Mar 31, 2021$24.36K-35.2%
Q4 FY2019CQ3 2019Sep 30, 2019$1.47K+28.2%
Q3 FY2019CQ2 2019Jun 30, 2019$231-95.0%
Q2 FY2019CQ1 2019Mar 31, 2019$412-99.9%
Q1 FY2019CQ4 2018Dec 31, 2018$37.61K+340.3%
Q4 FY2018CQ3 2018Sep 30, 2018$1.15K-96.9%
Q3 FY2018CQ2 2018Jun 30, 2018$4.62K+93.0%
Q2 FY2018CQ1 2018Mar 31, 2018$471.83K+18527.4%
Q1 FY2018CQ4 2017Dec 31, 2017$8.54K+299.0%
Q4 FY2017CQ3 2017Sep 30, 2017$36.81K+375.5%
Q1 FY2017CQ4 2016Dec 31, 2016$2.39K-85.0%
Q4 FY2016CQ3 2016Sep 30, 2016$2.53K-90.7%
Q3 FY2016CQ2 2016Jun 30, 2016$2.14K-92.6%
Q2 FY2016CQ1 2016Mar 31, 2016$7.74K–
Q1 FY2016CQ4 2015Dec 31, 2015$15.91K–
Q4 FY2015CQ3 2015Sep 30, 2015$27.28K–
Q3 FY2015CQ2 2015Jun 30, 2015$28.79K–

More Acro Biomedical figures

See a number that looks wrong?